MedPath

Ophtec BV

🇧🇪Belgium
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:1
Completed:3

Trial Phases

2 Phases

Phase 3:2
Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (50.0%)
Phase 3
2 (50.0%)

Clinical Trial With Artiflex Presbyopic (Artiplus)

Not Applicable
Active, not recruiting
Conditions
Hyperopia
Refractive Errors
Presbyopia
Myopia
Ametropia
First Posted Date
2020-11-17
Last Posted Date
2025-02-20
Lead Sponsor
Ophtec BV
Target Recruit Count
49
Registration Number
NCT04632784
Locations
🇰🇷

GM st. Mary's Eye clinic, Busan, Korea, Republic of

🇰🇷

SU Yonsei Eye Clinic, Seoul, Korea, Republic of

🇰🇷

Nune Eye Hospital Daegu, Seul, Korea, Republic of

and more 4 locations

Clinical Trial With PRECIZON Presbyopic

Not Applicable
Completed
Conditions
Cataract
Presbyopia
First Posted Date
2015-04-07
Last Posted Date
2017-04-04
Lead Sponsor
Ophtec BV
Target Recruit Count
70
Registration Number
NCT02409771
Locations
🇧🇪

Medipolis, Wilrijk, Belgium

🇩🇪

Universitäts-Augenklinik Heidelberg, Heidelberg, Germany

🇳🇱

Academisch Ziekenhuis Maastricht, Maastricht, Limburg, Netherlands

and more 3 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath